Consistent with the genomic categories, cases with a high tumor mutation burden (TMB) above 10 mutations/Mb had a higher prevalence in the group with suppressed SOX2 mRNA, while CIN metrics AS and FGA were more often high in the group with retained SOX2 expression (Table 2). This evidence concerns the gene SOX2 and neoplasm.